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Summary 
Prostaglandin endoperoxide synthase 2, also referred 
to as cyclooxygenase 2 (COX-2), is a key enzyme in 
the conversion of arachidonic acid to prostaglandins 
and other eicosanoids. Rat intestinal epithelial (RIE) 
cells were permanently transfected with a COX-2 ex- 
pression vector oriented in the sense (RIE-S) or anti- 
sense (RIE-AS) direction. The RIE-S cells expressed 
elevated COX-2 protein levels and demonstrated in- 
creased adhesion to extracellular matrix (ECM) pro- 
teins. E-cadherin was undetectable in RIE-S cells, but 
was elevated in parental RIE (RIE-P) and RIE-AS cells. 
RIE-S cells were resistant to butyrate-induced apop- 
tosis, had elevated BCL2 protein expression, and re- 
duced transforming growth factor p2 receptor levels. 
The phenotypic changes involving both increased ad- 
hesion to ECM and inhibition of apoptosis were re- 
versed by sulindac sulfide (a COX inhibitor). These 
studies demonstrate that overexpression of COX-2 
leads to phenotypic changes in intestinal epithelial 
cells that could enhance their tumorigenic potential. 
Introduction 
Arachidonic acid metabolites, collectively referred to as 
eicosanoids, such as hydroxyeicosatetraenoic acids 
(HETEs), prostaglandins, thromboxanes, and leukotri- 
enes affect a number of signal transduction pathways that 
modulate cellular adhesion, growth, and differentiation 
(Bronstein and Bull, 1993; Eberhart and DuBois, 1995; 
Marnett, 1992). Prostaglandin endoperoxide synthase 
(cyclooxygenase [COX]) is a key enzyme in the production 
of prostaglandins and other eicosanoids. Recently, a sec- 
ond isoform of this enzyme (prostaglandin endoperoxide 
synthase 2 or COX-2) has been identified, which is induc- 
ible by a variety of cytokines, hormones, and tumor pro- 
moters (DuBois et al., 1994a; Fletcher et al., 1992; Fu et 
al., 1990; Geng et al., 1995; Harris et al., 1994; Hla and 
Neilson, 1992; Jacksonetal., 1993;Simmonsetal., 1989). 
The enzymatic activity of both isoforms is inhibited by 
aspirin and other nonsteroidal antiinflammatory drugs 
(NSAIDs) (Marnett, 1992; Meade et al., 1993). The gastric 
side effects associated with intake of these drugs in hu- 
mans is thought to be related to inhibition of COX-1 (Eber- 
hart and DuBois, 1995), but the clinical effects related to 
COX-2 inhibition have not been fully evaluated (Klein et 
al., 1994; Seibert et al., 1994). Humans who take aspirin 
or other NSAlDs on a regular basis have a 40%-50% 
lower relative risk of colorectal cancer when compared 
with persons not taking these medications (Giovannucci 
et al., 1994; Greenberg et al., 1993; Thun et al., 1991, 
1993). 
The mechanism for reduction of colorectal cancer by 
NSAlDs is not clear, but NSAlDs are potent inhibitors of 
tumor formation in rodent models of chemically induced 
colon cancer (Reddy et al., 1987,1990,1992,1993), and 
treatment of familial adenomatous polyposis (FAP) pa- 
tients with NSAlDs results in a reduction in the number 
and size of adenomas present in the large intestine (Giar- 
diello et al., 1993; Waddell et al., 1989; Waddell and 
Loughry, 1983; Winde et al., 1993). Also, one NSAID, sulin- 
dac, was recently reported to increase the rate of pro- 
grammed cell death in the colonic epithelium of FAP pa- 
tients (Pasricha et al., 1995). In a separate study, NSAlDs 
were also shown to induce apoptosis in chicken embryo 
fibroblasts (Lu et al., 1995). The precise mechanism for 
the antitumor activity of these drugs or their effect on 
apoptosis is presently not understood. 
Previous work from our laboratory has demonstrated 
that the COX-2 gene is induced following growth factor or 
tumor promoter stimulation of parental rat intestinal epi- 
thelial (RIE-P) cells (DuBois et al., 1994a, 1994b). We have 
also reported that COX-2 mRNA levels are markedly in- 
creased in 86% of human colorectal adenocarcinomas 
(Eberhart et al., 1994). However, COX-1 expression is un- 
affected during colorectal carcinogenesis. Studies from 
other laboratories have confirmed our findings and shown 
that COX-2 protein levels are increased in a significant 
number of colorectal carcinomas as well (Kargman et al., 
1995). 
The aim of the present study was to evaluate RIE cells 
for phenotypic and biochemical changes associated with 
COX-2 overexpression. Gene disruption approaches can 
be employed to determine the biological effect of a lack 
of these enzymes. We chose to overexpress COX-2 in 
intestinal epithelial cells, since COX-1 was not regulated 
during colorectal carcinogenesis. Cells permanently trans- 
fected with a COX-2 expression vector exhibited distinct 
phenotypic changes as demonstrated by alterations in 
adhesion to extracullular matrix (ECM) proteins and inhibi- 
tion of apoptosis following butyrate treatment. We also 
found that BCL2 levels were high in RIE-S cells com- 
pared with RIE-P or RIE-AS controls, which may relate to 
their resistance to undergo apoptosis. Other biochemical 
changes in the RIE-S cells included decreased expression 
of both E-cadherin and transforming growth factor p2 
(TGFP2) receptor. E-cadherin is involved in cell-cell adhe- 
sion, and TGFBP receptors transduce signals important 
in modulating programmed cell death. 
Our findings suggest that COX-2 overexpression is 
linked to changes in cellular adhesion and inhibition of 
apoptosis. Since COX-2 is expressed at high levels in colo- 
rectal carcinomas and NSAlDs (like aspirin) decrease the 
relative rate of colorectal cancer in humans, our results 
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may offer some insight into the chemoprotective effects 
of NSAIDs. An improved understanding of the molecular 
mechanisms underlying these effects may reveal addi- 
tional molecular targets for new drugs and lead to novel 
strategies for the development of other cancer chemopre- 
ventive agents. 
Results 
Preparation of RIE Cells That Constitutively 
Overexpress COX-2 
COX-2 is undetectable in quiescent RIE cells, but is tran- 
siently induced 6- to lo-fold within 6 hr of growth factor 
treatment (DuBois et al., 1994a). To examine the effect 
of COX-2 expression on intestinal epithelial cells, RIE cells 
were transfected with the eukaryotic expression vector, 
pCB7, containing the COX-2 coding region in the sense 
(RIE-S) and antisense (HE-AS) orientations. We isolated 
225 stable transfectants in each group and used 5 clones 
with high (RIE-S) and low (RIE-AS) prostaglandin produc- 
tion relative to the parental line (RIE-P) for further studies. 
To evaluate COX-2 expression levels in RIE-S and RIE-AS 
cells, Western blot analysis and COX assays were carried 
out. As shown in Figure 1 A, the anti-COX-2 antibody de- 
tected a protein of the expected molecular mass (69,000 
Da) in the sense vector-transfected cells that was absent 
in the antisense cell lines. In addition, there was a marked 
increase in arachidonate conversion to eicosanoid prod- 
ucts in RIE-S compared with RIE-AS cells, which was in- 
hibited by sulindac sulfide in a dose-dependent manner 
(Figure 1 B). The levels of 6-keto-PGF,, production (an in- 
dex of PG12 synthesis), determined as previously de- 
scribed (DuBois et al., 1994b), were 9.58 + 0.14 ng x 
1 Om5 cells for RIE-S without sulindac sulfide, 0.091 f 0.03 
ng x 10-5cellsforRIE-Sin thepresenceof 1OpMsulindac 
sulfide, and 0.043 + 0.01 ng x 10e5 cells for RIE-AS. 
Previous work has demonstrated that RIE-P cells produce 
0.8 ng x 10m5 cells of 6-keto-PGF,. (DuBois et al., 1994a). 
These results demonstrate a greater than 1 O-fold increase 
in COX protein levels and enzymatic activity in RIE-S cells 
compared with RIE-AS cells and that 10 PM sulindac sul- 
fide dramatically inhibited prostaglandin production in 
these cells. 
COX-2 Overexpression Causes Increased Binding 
of RIE Cells to Selected ECM Proteins 
Since COX-2 is induced in intestinal epithelial cells by 
growth factors and tumor promoters, we initially hypothe- 
sized that the stable expression of COX-2 might have an 
effect on mitogenesis, but have demonstrated that mito- 
genesis is not increased in COX-P-overexpressing cells 
(data not shown). Therefore, other important aspects of 
cell growth control and differentiation were evaluated. In 
intestinal mucosa in vivo, continuously proliferating stem 
cells are located in the crypt region. Both cellular differenti- 
ation and proliferative arrest are induced as intestinal stem 
cells ascend upward on basement membrane along the 
crypt-villus axis toward the gut lumen. When the cells 
reach the surface of the villi, they become fully differenti- 
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Figure 1. COX-2 Expression and Enzymatic ActivitV i;‘RIk Cetls 
(Ai Western blot analysis for COX-2 expression. The arrow &&stsiid” 
the 69,000 Da COX-2 band. RIE-P cells transfected with sense (dl& 
and antisense (RIE-AS) oriented COX-2 cDNA were growq i*DMEM 
supplemented with 10% fetal bovine serum (FBS). The cells were 
harvested and lysed in RIPA buffer. Protein (100 Ng) of the cell lysate 
samples was separated on 12.5% SDS-polyacrylamide gels. Cellular 
expression of COX-2 was detected by using a rabbit polyclonal antise- 
rum (DuBois et al., 1994a) by Western blotting procedures following 
the instructions of the manufacturer (ECL system; Amersham). 
(B) COX enzyme assay. The cells were harvested and resuspended 
in PBS containing 25 PM [‘4C]arachidonate for 15 min at 25OC with 
constant mixing. The organic soluble reaction products were extracted 
into ethyl acetate and separated by reverse-phase HPLC using a WBon- 
dapak Cl8 column utilizing an acetonitrile-water gradient. The radioac- 
tive metabolites in the eluent were monitored by an on-line scintillation 
counter. The COX activity was estimated by arachidonic acid conver- 
sion rate (nmolelmg protein). 
ated, apoptosis is activated, and the cells are shed into 
the lumen. In rodent small intestine, the entire lifetime 
of an epithelial cell is only 3-4 days, indicating that the 
turnover of epithelial cells is rapid. Therefore, cellular dif- 
ferentiation and apoptosis are important factors in main- 
taining the integrity and function of intestinal mucosa. Al- 
terations is these processes could have significant 
biological consequences and effect the tumorigenic po- 
tential of epithelial cells. 
RIE-P cells are derived from normal undifferentiated in- 
testinal crypt cells and do not spontaneously undergo dif- 
ferentiation in culture (DuBois et al., 199413). Other non- 
transformed intestinal cells, such as IEC-6 cells, have 
been reported to show cellular differentiation and prolifera- 
tive arrest when plated on ECM preparations such as Ma- 
trigel, a model basement membrane (Carroll et al., 1988). 
These results suggested that interactions between epithe- 
COX-2 Expression Alters Apoptosis and Adhesion 
495 
C 
‘+r 
Figure 2. Adhesion of RIE Cells To ECM-Coated Plates 
(A) Photomicrograph of NE-AS and RIE-S cells attached to laminin-coated plates. For this experiment, 4 x 105 cells were plated on plates precoated 
with purified laminin. The plates were incubated at 37OC for 45 min, and the wells were washed to remove unattached cells. Photomicrographs 
were then taken of the plates using phase-contrast microscopy. Total magnification is 30x. 
(B-D) Effect of COX-2 overexpression of cellular attachment to laminin (B), Matrigel (C), and fibronectin (D): 4 x lo5 cells of each group cultured 
in media without serum for 3 days were plated into 2 cm2 wells coated with Matrigel, laminin, or fibronectin. After the plates were incubated at 
37% for 45 min, the wells were washed to remove unattached cells. Attached cells were incubated for 1 hr in dipase and resuspended, and cell 
counts were determined with a hemocytometer. Five independent clones from each group were tested for phenotypic differences, and they all 
demonstrated the identical phenotype (data not shown). The results shown here are from studies of one indeoendent clone and were done in 
quadruplicate. 
lial cells and ECM have an important effect on induction 
of cellular differentiation and apoptosis. Therefore, we ex- 
plored the ability of RIE cell lines to adhere to selected 
components of ECM. As shown in Figure 2A, there is a 
clear phenotypic difference in the RIE-S and RIE-AS cells 
in their ability to bind to laminin-coated plates. 
To quantitate this effect in each group (RIE-P, RIE-AS, 
and RIE-S), 4 x lo5 cells were plated on Matrigel-, lami- 
nin-, or fibronectin-coated wells, and the number of cells 
bound to ECM-coated plates over 45 min was determined. 
As shown in Figures 2EL2D, the number of RIE-S cells 
that attached to Matrigel and laminin was g-fold higher 
than the number of RIE-P and RIE-AS cells. These results 
suggest that COX-2 expression increased the ability of 
cells to attach to laminin and Matrigel, but it is of interest 
that each group of cells bound tofibronectin-coated plates 
equally well (Figure 2D), indicating that not all components 
of the extracellular adhesion pathway were affected. 
Next, we investigated the kinetics of binding to Matrigel. 
Three groups of cells (RIE-P, RIE-AS, and RIE-S) were 
cultured on Matrigel for 14 days, and at various intervals, 
the number of attached cells were counted. As shown in 
Figure 3, RIE-S cells continue to grow slowly over the 2 
week period, while RIE-P and RIE-AS cells showed a grad- 
ual decline in cell number. RIE-AS cells detached com- 
pletely from ECM within 72 hr of plating, and RIE-P cells 
detached within 7 days, whereas all of the RIE-S cells 
remained attached to the cell culture plate for 2 weeks. 
The results with RIE-P and RIE-AS cells concur with those 
reported using IEC-6 cells (Carroll et al., 1988). Our results 
suggested that the cells expressing COX-2 can attach to 
basement membrane and survive on it, whereas cells in 
which COX-2 expression is undetectable (RIE-AS) are un- 
able to do so. This clearly demonstrated that the extracel- 
lular adhesion pathway was altered by COX-2 overexpres- 
sion and suggested that cell survival was affected as well. 
COX-2 Expression Increases Resistance 
to Apoptosis in RIE Cells 
In light of the above results, we investigated the effect of 
COX-2 overexpression on apoptosis using two indepen- 
dent techniques: analysis of DNA fragmentation and stain- 
ing with a DNA-specific dye (Hoechst 33258). Analysis of 
the RIE-AS cells revealed oligonucleosomal DNA frag- 
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Figure 3. Effect of COX-2 Overexpression on Cell Kinetics of Binding 
to Matrigel-Coated Plates 
RIE-S cells (closed circles), RIE-P (open squares), and RIE-AS (open 
circles) cells (4 x 105) were plated into 24-well plates coated with 
Matrigel. At various intervals, the cells were washed with PBS, and 
dipase was added to the cell culture plates for 1 hr. The cells were 
then resuspended, and cell counts were determined using a hemocy- 
tometer. 
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Figure 4. Effect of COX-2 Expression on Apoptosis in RIE Cells 
(A) Evaluation of apoptosis using DNA laddering. The electrophoretic 
pattern of DNA isolated from RIE-S and RIE-AS cells is shown. DNA 
was extracted from the RIE cells cultured on Matrigel for 3 days and 
analyzed on a 1% agarose gel. Lane M, 1 kb DNA ladder; lane A, 
RIE-AScells; lane S, RIE-Scells. Identical resultswereobtainedfollow- 
ing 48 hr of treatment with 5 mM sodium butyrate. 
(6) Evaluation of apoptosis using fluorochrome staining. RIE cellswere 
cultured on Matrigel for 3 days, fixed in glutaraldehyde, and stained 
with the DNA-specific fluorochrome bis-benzimide (Hoechst 33258). 
The results with RIE-S cells are denoted by the letter a, and results 
with RIE-AS cells are denoted by the letter b. Identical results were 
observed for cells following treatment with 5 mM sodium butyrate for 
48 hr. Total magnification is 71 x 
mentation that results in a DNA ladder containing 180 bp 
fragments when analyzed by neutral agarose gel electro- 
phoresis. DNA laddering such as that demonstrated in 
Figure 4A was routinely observed within 24 hr following 
plating of RIE-AS and WE-P cells on ECM but was not 
observed for WE-S cells. Plating of WE-AS cells on ECM 
also resulted in the appearance of typical morphological 
changes of apoptosis upon staining the cells with the 
DNA-specific fluorochrome bis-benzimide trihydrochlor- 
ide (Hoechst 33258) as demonstrated in Figure 48. These 
changes included condensation of chromatin, its compac- 
tion along the periphery of the nucleus, and segmentation 
of the nucleus. 
Other intestinal epithelial cell lines have been reported 
to undergo differentiation and apoptosis when treated with 
sodium butryate (Hague et al., 1993), so the effect of so- 
dium butyrate on RIE cells in culture was examined. RIE 
cells cultured in medium containing sodium butyrate un- 
derwent apoptosis within 3 days in a distinct and reproduc- 
ible fashion. As shown in Figures 5A and 5B, a significant 
number of RIE-P and RIE-AS cells cultured under these 
conditions became apoptotic. However, we observed very 
few apoptotic RIE-S cells following butyrate treatment. 
Addition of a COX inhibitor (sulindac sulfide) allowed 
apoptosis to occur in RIE-S cells following butyrate treat- 
ment or when the cells were plated on Matrigel. These 
Figure 5. Effect of COX-2 Overexpression on Apoptosis 
(A) We plated 1 x 106cells of each group on each 10 cm2well coated 
with Matrigel, and afler 24 hr of culture, the wells were washed with 
PBS. The media was replaced, and the cells were cultured for an 
additional 3 days. The ratio of apoptotic cells was determined by nu- 
clear staining. Cells with three or more chromatin fragments were 
considered apoptotic. 
(B) Confluent cell cultures were established in 10 cm2 wells, and the 
medium was replaced with fresh medium containing 5 mM sodium 
butyrate. After 4 days, the percentage of apoptotic cells was deter- 
mined by nuclear staining as described above. 
results represent additional evidence that overexpression 
of COX-2 inhibits apoptosis induced by butyrate treatment 
or by plating the cells on ECM. Addition of sulindac sulfide 
at the concentrations used in thisstudy to RIE-S cells alone 
(without butryate or ECM) resulted in less than 5% of the 
cells undergoing apoptosis (data not shown). 
COX-2 Expression Affects Key Regulatory 
Proteins in RIE Cells 
Alkaline Phosphatase 
To examine the effect of COX-2 expression on a marker 
of intestinal epithelial differentiation, alkaline phosphatase 
activity (Carroll et al., 1988; Herz et al., 1981) was evalu- 
ated. In vivo, after cells migrate from the undifferentiated 
crypt compartment to the luminal villus compartment, the 
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Figure 6. Effect of COX-2 Overexpression on Cellular Differentiation 
Cellular differentiation was measured by alkaline phosphataseactivity. 
(A) We plated 1 x 10” cells of each group on each 10 cm* well coated 
with Matrigel. After 24 hr, the cells were washed with PBS and cultured 
foranadditional48 hr.Aftertheculturemediawasremoved, theculture 
plates were incubated with 0.5 ml of Dipase (Collaborative Research) 
for 45 min. The cells were washed twice with TBS. The cells were 
lysed in a 200 pl of TBS containing 0.25% sodium deoxycholate for 
30 min at room temperature. The lysate wasthen centrifuged at 10,000 x 
g for 15 min at 4°C. Alkaline phosphatase activity was measured at 
30% usingthealkalinephosphatase kitpurchasedfromSigmaChemi- 
cal Company following the instructions of the manufacturer. 
(B) Confluent cells of each group were established in 10 cm2 wells and 
cultured in media containing 5 mM sodium butyrate for an additional 4 
days. Floating and attached cells were collected (following trypsiniza- 
tion), mixed, and washed twice with PBS. Preparation of cell lysates 
and measurement of alkaline phosphatase activity were carried out 
as described above. 
expression of alkaline phosphatase increases dramati- 
cally (Ferraris et al., 1992; Hodin et al., 1994). Since ex- 
pression of this enzyme is related to intestinal epithelial 
differentiation, we measured alkaline phosphatase activity 
in various RIE cell lines to obtain information about the 
state of differentiation of these cells. RIE-AS and NE-P 
cells were cultured on dishes coated with Matrigel for 3 
days or on plastic and then treated with sodium butyrate. 
A 
Butyrate Stimulated ECM 
RI&P RIEAS RIES RIE-P RIE-AS RUGS :: 
Bcl-2 -b .*. ?; Bcl-2 -b 
B Butyrate Stimulated ECM 
RIE-P RIE-AS RIE-S RI&P RIE-AS RIE-S 
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C Butyrate Stimulated ECM 
RIE-P RI&AS FgE-S RIE-P RIE-AS RIE-S 
E-cadherin + 
Figure 7. Western Blot Analysis for BCLP, E-Cadherin, and TGF52 
Receptor Protein Levels 
RIE-P, RIE-S, and RIE-AS cells were grown in Dulbecco’s modified 
Eagle’s medium supplemented with 10% fetal bovine serum (FBS). 
The cells were plated on plastic dishes and treated with sodium buty- 
rate or grown on Matrigel. The cells were harvested and lysed in RIPA 
buffer. Protein (100 kg) of the cell lysate samples was separated on 
12.5% SDS-polyacrylamide gels. Cellular expression of BCL2 (A) and 
TGF52 receptor(B) were detected using a commercially available rab- 
bit polyclonal antibody, and E-cadherin (C) was detected using a 
mouse IgG2a monoclonal antibody by Western blotting procedures 
(ECL system; Amersham). 
The NE-AS cells, which have undetectable COX levels, 
showed high levels of alkaline phosphatase activity com- 
pared with RIE-S cells (Figures 6A and 6B). In the presence 
of increasing sulindac sulfide concentrations, RIE-S cells 
showed increased alkaline phosphatase activity. The ef- 
fect was more pronounced when the cells were plated on 
plastic culture dishes (Figure 6B) and treated with sodium 
butyrate compared with the cells plated on Matrigel-coated 
plates. These results also demonstrate that the effect of 
COX-2 overexpression can be reversed by adding an in- 
hibitor of the enzyme, such as sulindac sulfide. 
BCLS, TGFP2 Receptor, and E-Cadherin 
BCL2 expression has been linked to inhibition of apoptosis 
in several different cell types (Hague et al., 1994; Kors- 
meyer, 1992). Because the RIE-S cells were resistant to 
apoptosis, we measured BCL2 protein levels to see 
whether they correlated with this phenotype. As shown in 
Figure 7A, BCL2 levels were elevated in RIE-S cells plated 
on plastic and treated with sodium butryate, but were even 
higher in RIE-S cells plated on Matrigel. BCL2 expression 
was undetectable in RIE-P or RIE-AS cells under either 
condition tested. TGFf32 receptors and E-cadherin have 
both been implicated in colorectal tumorigenesis. TGFf32 
receptors were found to be inactivated in a subset of colon 
cancer cell lines that exhibited microsatellite instability 
(Markowitz et al., 1995). Therefore, we measured TGF62 
receptor protein levels in RIE-S, RIE-AS, and RIE-P cells. 
We found that TGFf32 receptor levels were much lower in 
the RIE-S cells either treated with butyrate or plated on 
ECM (Figure 7B). Down-regulation of E-cadherin has been 
reported to occur in a variety of solid tumors (Mayer et 
al., 1993; Shimoyamaand Hirohashi, 1991a, 1991 b; Shio- 
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zaki et al., 1991) and is closely related to tumor invasion 
(Sommers et al., 1991). Utilizing Western blotting, we 
quantitated E-cadherin levels in RIE-S and RIE-AS cell 
lines either plated on ECM or treated with butyrate. As 
seen in Figure 78, we found that E-cadherin protein was 
undetectable in the RIE-S cells but was highly expressed 
in the RIE-AS cells. Taken together, these results demon- 
strate biochemical changes in RIE-S cells that could en- 
hance their tumorigenic potential. 
Discussion 
We have shown here a number of phenotypic changes in 
RIE-S cells that overexpress COX-2. In particular, they 
attach to ECM components (e.g., laminin) with greater 
avidity than cells that do not express this enzyme, express 
lower levels of TGF82 receptor and E-cadherin, resist un- 
dergoing apoptosis when stimulated to do so, and express 
high levels of BCLP protein. Each of these changes could 
enhance the tumorigenic potential of intestinal epithelial 
cells. Since COX-2 expression levels increase dramati- 
cally in colorectal cancer (Eberhart et al., 1994; Kargman 
et al., 1995), our findings may relate to the ability of COX 
inhibitors, such as aspirin and other NSAIDs, to reduce 
the relative risk of colorectal cancer in humans. 
The results of this work demonstrate that COX-2 overex- 
pression may alter intestinal epithelial biology in a number 
of ways. Several studies suggest that cell-substrate adhe- 
sion may play an important role in tumorigenicity, since 
cells that have been transformed by a virus or with chemi- 
cal carcinogens demonstrate altered adhesion to ECM 
compared with nontransformed cells(Behrens et al., 1989; 
Dedhar and Saulnier, 1990; Plantefaber and Hynes, 1989). 
Other groups have reported that cellular attachment to 
laminin had a positive effect on cell proliferation, whereas 
attachment to fibronectin-inhibited proliferation (Giancotti 
and Ruoslahti, 1990). Programmed cell death is one of the 
most important components in maintaining the integrity of 
intestinal epithelium. Cellular differentiation and prolifera- 
tive arrest are induced as intestinal stem cells ascend up- 
ward on basement membrane along the crypt-villus axis 
toward the intestinal lumen. When the cells reach the sur- 
face of the villi, they become fully differentiated, undergo 
programmed cell death, and are shed into the lumen. The 
entire lifetime of an epithelial cell in humans is only 4-5 
days. Factors that could prolong cell survival could influ- 
ence the integrity and function of intestinal mucosa. Addi- 
tionally, prolonged cell survival and increased adhesion 
to matrix components could have significant biological 
consequences and effect the tumorigenic potential of epi- 
thelial cells. Recently, the study of apoptosis has become 
the focus of a number of groups evaluating the molecular 
basis for the development of colorectal cancer (Hague et 
al., 1993; Markowitz et al., 1995; Pasricha et al., 1995). 
Prolonged survival of abnormal cells can favor tumor pro- 
gression and facilitate the accumulation of sequential ge- 
netic mutations that would result in tumor promotion. In 
the context of intestinal epithelium in vivo, high COX-2 
levels would increase the time that abnormal cells (with 
a 1 o mutation) would spend in transit to the villus tip and 
increase the chance that a second mutation could occur 
(tumor progression). Our results are consistent with this 
hypothesis, as they demonstrate that RIE-S cells have pro- 
longed survival under conditions in which apoptosis is nor- 
mally induced. They also support a protective role of 
NSAIDs, since following inhibition of COX the cells un- 
dergo programmed cell death quite readily. 
The effect of COX-2 overexpression on TGF82 receptor 
and E-cadherin expression levels could also play a signifi- 
cant role in tumorigenesis. TGF8 inhibits the growth of 
epithelial cells (Barnard et al., 1989), and some reports 
have indicated that loss of this negative regulation contri- 
butes to colorectal tumor development (Markowitz et al., 
1994). The TGF8 growth inhibitory signal is transduced 
through both the TGF81 and TGF82 receptors (Lin and 
Moustakas, 1994; Lin et al., 1995). It was recently demon- 
strated (Markowitz et al., 1995) that TGF82 receptor tran- 
scripts were undetectable or present at markedly reduced 
amounts in some human colon cancer cell lines, although 
TGFbl receptor transcripts were detected in all samples. 
Reduced TGFf32 receptor expression, by inducing the es- 
cape of cells from TGF8-mediated growth control, would 
also increase the probability that cells expressing high 
COX-2 levels would have prolonged survival and at risk 
for tumor progression. 
Down-regulation of E-cadherin has been reported to oc- 
cur in multiple solid tumors (Mayer et al., 1993; Shimo- 
yama and Hirohashi, 1991a, 1991b; Shiozaki et al., 1991) 
and is closely related to invasion (Sommers et al., 1991). 
Additional evidence supports the idea that E-cadherin may 
act as an invasion-suppressor gene (Behrens et al., 1989; 
Frixen et al., 1991; Oka et al., 1993). For tumor formation, 
local invasion is thought to be one of the most important 
factors. Moreover, some reports have shown that more 
than 80% of poorly differentiated tumors lack expression 
of E-cadherin. These results suggest that the presence 
of E-cadherin is important in cell differentiation and that 
down-regulation of E-cadherin expression is associated 
with local invasion of tumor cells. 
Colorectal cancer is the second leading cause of death 
from cancer in the United States. In early stages of the 
disease a cure is possible, but unfortunately, these malig- 
nancies have often grown beyond the large intestine bythe 
time they are detected and our current treatment regimens 
are not very effective. Work carried out by several groups 
over the last decade has focused on the molecular basis 
of colorectal cancer, and tremendous progress has been 
made. Clinical investigators have observed a 400/o-50% 
reduction in the relative riskof colorectal cancer in humans 
who take NSAlDs (like aspirin) on a regular basis. One 
of the molecular targets for NSAlDs is COX. Our work 
presented here demonstrates that when intestinal epithe- 
lial cells overexpress one of the COX isoforms (COX-2), 
they adhere more avidly to ECM proteins and are resistant 
to apoptosis. Both of these phenotypic changes are re- 
versed by the addition of a COX inhibitor (sulindac sulfide). 
These results may provide some insight regarding the mo- 
lecular basis for the chemoprotective effects of NSAIDs. 
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Experimental Procedures 
Cell Culture 
RIE-1 cells were a gift from K. D. Brown (Cambridge Research Station, 
Babraham, Cambridge, England). Cellswere grown in Dulbecco’s min- 
imal essential medium (DMEM) supplemented with 10% fetal bovine 
serum (lot number 11151032; Hyclone Laboratories, Logan, UT), 2 mM 
L-glutamine, 100,000 U/I penicillin G, and 100,000 lg/l streptomycin 
sulfate. 
Stable Transfection 
A 2.1 kb Smal-EcoRV fragment containing the open reading frame 
for a polypeptide of 604 amino acids of fat COX-2 was isolated and 
blunt end cloned into the Smal site of the eukaryotic expression vector, 
pCB7 (a gift of R. Coffey, Vanderbilt University). In this vector, tran- 
scription of the cDNA is controlled by the CMV promoter. This vector 
also contains a bacterial hygromycin resistance gene expression cas- 
sette that allows for selection in hygromycin B. Sense- and antisense- 
oriented expression vectors were prepared. These expression vectors 
were transfected into a nontransformed RIE cell line (RIE-1) using a 
Lipofectin (GIBCO-BRL) transfection method (DuBois et al., 1994b), 
and the cells were selected in medium containing hygromycin B (225 
U/ml). Total RNA was prepared from the cells transfected with sense- 
oriented expression vector and evaluated using Northern slot blot anal- 
ysis. Five clones (SlO, S99, S123, S132, and S146) expressing the 
highest level of COX-2 RNA were identified from 225 initial clones and 
expanded. We characterized all five clones and found that they all 
exhibited the identical phenotypic and biochemical alterations. There- 
fore, the results of our studies using the RIE-SlO clone are presented 
here. The RIE cells transfected with antisense expression vector (RIE- 
AS) were evaluated in a similar manner. It is important to note from 
previous studies that RIE cells have undetectable levels of COX-7 
mRNA and protein (DuBois et al., 1994a). 
Western Blotting 
To confirm the expression of COX-2 in sense-transfected cells, West- 
ern blot analysis and COX enzyme assays were done. RIE cells 
transfected with the sense- and antisense-oriented COX-2 cDNA were 
grown in DMEM supplemented with 10% fetal bovine serum (FBS). 
The cells were harvested and lysed in RIPA buffer (PBS, 1% NP-40, 
0.5% sodium deoxycholate, 0.1% SDS, 100 rig/ml PMSF, 66 nglml 
aprotinin). Samples containing 100 Kg of cell lysate protein were sepa- 
rated on 12.5% SDS-polyacrylamide gels. Total protein was assayed 
using protein assay reagent (Pierce, catalog number 23225). COX-2 
protein levels were detected by using a rabbit polyclonal antibody 
(DuBois et al., 1994a) and by using standard detection techniques 
(ECL system; Amersham). 
For Western blotting of BCL2, the cells were cultured on Matrigel 
(Collaborative Biomedical Products, catalog number 40230) or in me- 
dium containing 5 mM sodium butyrate (Sigma Chemical Company) 
for 24 hr, harvested, and lysed in RIPA buffer. Samples containing 
100 @g of protein were separated on 15% SDS-polyacrylamide gels. 
BCLP protein levels were determined using a rabbit polyclonal anti- 
body (Santa Cruz, catalog number SC-492) and standard detection 
techniques (ECL system; Amersham). ForTGF82 receptor and E-cad- 
herin Western blot analysis, cell lysates containing 100 Fg of protein 
were separated on 7.5% SDS-polyacrylamide gels. TGF82 receptor 
expression was detected by using a rabbit polyclonal antibody (Santa 
Cruz, catalog number SC-400) that has been carefully evaluated and 
does not cross-react with TGF81 receptor. E-cadherin expression was 
detected using a mouse monoclonal anti-human E-cadherin antibody 
(Transduction Laboratories, catalog number C20820). 
COX Assays 
For COX enzyme assays, the cells were harvested and resuspended in 
phosphate-buffered saline (PBS) containing 25 VM [“‘C]arachidonate 
(DuPont-New England Nuclear) for 15 min at 25°C with constant mix- 
ing. VariOUS concentrations of sulindac sulfide were added in selected 
experiments. The organic soluble reaction products were extracted 
into ethyl acetate and separated by reverse-phase HPLC using a pBon- 
dapak CM column (Waters) utilizing an acetonitrile-water gradient. 
The radioactive metabolites in the eluent were monitored by an on-line 
scintillation counter(DuBois et al., 1994b). The COX activity was calcu- 
lated by arachidonic acid conversion rate (nmolelmg protein). 
Cell Attachment Studies 
Cells (4 x 1 05) of each group were plated into 2 cm* wells coated with 
Matrigel, laminin (Collaborative Biomedical Products, catalog number 
40232), or fibronectin (Collaborative Biomedical Products). After the 
plates were incubated at 37OC for 45 min, the wells were washed with 
PBS (9.1 mM dibasic sodium phosphate, 1.7 mM monobasic sodium 
phosphate, 150 mM NaCl [pH 7.41) to remove unattached cells. 
Attached cells were incubated for 1 hr in dipase (Collaborative Biomed- 
ical Products, catalog number 40235) and resuspended, and cell 
counts were determined using a hemocytometer. 
For cell culture on Matrigel, 4 x lo5 of RIE-S, RIE-P, and RIE-AS 
transfected cells were plated into 24-well plates coated with Matrigel. 
At various time intervals, cells were washed with PBS and incubated 
in dipase for 1 hr. The cells were resuspended, and cell counts were 
determined using a hemocytometer. 
Alkaline Phosphatase Activity 
Alkaline phosphatase activities of the cells were determined as a 
marker of cell differentiation. 
Culture on Mafrigel 
We plated 1 x lo6 cells of each group on each 10 cm2 well coated 
with Matrigel. After 24 hr, the cells were washed with PBS and cultured 
for an additional 48 hr in the presence of various concentrations of 
sulindac sulfide (with media changes every 12 hr). Following this incu- 
bation period, the culture media were removed, and the culture plates 
were incubated with 0.5 ml of Dipase (Collaborative Research) for 45 
min. After the cells were washed twice with TBS (10 mM Tris-HCI, 
150 mM NaCI), they were lysed in a 200 trl of TBS containing 0.25% 
sodium deoxycholate for 30 min at room temperature. The lysate was 
then centrifuged at 10,000 x g for 15 min at 4’C. Alkaline phosphatase 
activity was measured at 30°C using a commercial alkaline phospha- 
tase kit (Sigma Chemical Company, catalog number 245-10). 
Culture in Media Containing Sodium Butyric Acid 
Confluent cells of each group were established in 10 cm2 wells and 
cultured in the media containing 5 mM sodium butyrate and various 
concentrations of sulindac sulfide for an additional 96 hr (with media 
changes every 12 hr). The cells were washed with TBS prior to harvest. 
Apoptosis 
Culture on Matrigel 
We plated 1 x lo6 cells of each group (RIE-P, RIE-AS, and RIE-S) 
on 10 cm2 wells coated with Matrigel, and after 24 hr of culture, the 
cells were washed with PBS. The media was replaced, and the cells 
were cultured for an additional 72 hr and various concentrations of 
sulindac sulfide were added (with media changes every 12 hr). 
Culture in Media Containing Sodium Butyric Acid 
Confluent cell cultures were established in 10 cm* wells, and the me- 
dium was replaced with fresh medium containing 5 mM of sodium 
butyrate and various concentrations of sulindac sulfide every 12 hr. 
After 96 hr, the percentage of floating cells was calculated. 
DNA was extracted from RIE cells cultured on Matrigel or treated 
with 5 mM sodium butyrate and analyzed on a 1% agarose gel. Nuclei 
of floating cells and attached cells were stained with a DNA-specific 
fluorochrome bis-benzimide trihydrochloride (Hoechst 33258: Sigma 
Chemical Company). After fixing cells with glutaraldehyde, cells were 
stained in 167 WM bis-benzimide and observed under fluorescent mi- 
croscopy. Cells with three or more chromatin fragments were consid- 
ered apoptotic. 
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